Arsani William, Director at Design Therapeutics, Inc. (DSGN), bought 40,000 shares at $15.45 ($618K) on 2021-08-31, disclosed to the SEC on 2021-09-02.
Open-market purchase of $618k DSGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| DSGN | BUY | 2023-08-30 | $5.4M | — | Filing → |
| DSGN | BUY | 2022-03-22 | $950K | — | Filing → |
| DSGN | BUY | 2021-04-01 | $14.0M | — | Filing → |